| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10592770 | Bioorganic & Medicinal Chemistry Letters | 2014 | 6 Pages |
Abstract
In this Letter we describe SAR investigation on the cyclopentyl-triazolol-pyrimidine scaffold in pursuit of new oral P2Y12 inhibitors. Different synthetic routes were developed for variations at the cyclopentyl core. Optimization finally led to compound 2d which was advanced into preclinical development based on better potency and safety profile in comparison to ticagrelor.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Wangyang Tu, Jiang Fan, Haitang Zhang, Guoji Xu, Zhiwei Liu, Jian Qu, Fanglong Yang, Lei Zhang, Tianyu Luan, Jijun Yuan, Aishen Gong, Jun Feng, Piaoyang Sun, Qing Dong,